Inactive Instrument
Pandion Therapeutics, Inc. Share Price
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 01/08/2020 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/21/01 | Tender | Chief Technology Officer | 3,35,035 | 1.1351% | ||
| 01/21/01 | Tender | Director | 14,997 | 0.0508% | ||
| 01/21/01 | GSK Equity Investments Ltd.
| Tender | Company | 56,88,218 | 19.2719% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 170.43Cr | |
| -2.48% | -3.13% | +55.85% | +89.65% | 5.49TCr | |
| -0.55% | -8.57% | +58.09% | +124.47% | 5.46TCr | |
| -5.60% | -2.15% | +7.12% | +420.46% | 2.51TCr | |
| -1.55% | -4.11% | -18.86% | -17.75% | 2.31TCr | |
| -1.69% | -0.64% | +40.04% | -0.48% | 1.99TCr | |
| +1.87% | +4.16% | +38.74% | -26.42% | 1.75TCr | |
| -2.72% | -0.60% | +187.08% | +351.91% | 1.65TCr | |
| -2.42% | +1.00% | +48.24% | +635.77% | 1.57TCr | |
| -0.81% | +0.92% | +22.95% | +189.61% | 1.42TCr | |
| Average | -1.52% | -0.82% | +48.80% | +196.36% | 2.68TCr | |
| Weighted average by Cap. | -1.75% | -1.56% | +48.14% | +165.10% |
Employees
56
Choose MarketScreener 
